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Accurate control of the Ras-related nuclear protein
(Ran) GTPase cycle depends on the regulated
activity of regulator of chromosome condensation 1
(RCC1), Ran’s nucleotide exchange factor. RanBP1
has been characterized as a coactivator of the Ran
GTPase-activating protein RanGAP1. RanBP1 can
also form a stable complex with Ran and RCC1,
although the dynamics and function of this com-
plex remain poorly understood. Here, we show that
formation of the heterotrimeric RCC1/Ran/RanBP1
complex in M phase Xenopus egg extracts controls
both RCC1’s enzymatic activity and partitioning
between the chromatin-bound and soluble pools
of RCC1. This mechanism is critical for spatial
control of Ran-guanosine triphosphate (GTP) gradi-
ents that guide mitotic spindle assembly. Moreover,
phosphorylation of RanBP1 drives changes in the
dynamics of chromatin-bound RCC1 pools at the
metaphase-anaphase transition. Our findings reveal
an important mitotic role for RanBP1, controlling
the spatial distribution and magnitude of mitotic
Ran-GTP production and thereby ensuring accurate
execution of Ran-dependent mitotic events.
INTRODUCTION
The Ras-related nuclear protein (Ran) GTPase plays critical roles
inmultiple cellular processes including nucleocytoplasmic trans-
port, nuclear envelope (NE) assembly, and mitotic spindle as-
sembly (Clarke and Zhang, 2008). In interphase, guanosine
triphosphate (GTP)-bound Ran (Ran-GTP) is concentrated within
the nucleus, while guanosine diphosphate (GDP)-bound Ran
(Ran-GDP) is predominant in the cytoplasm. This asymmetrical
distribution drives transport between the nucleus and cytoplasm
by regulating cargo binding and release of a family of Ran-GTP-
binding transport receptors that are collectively called karyo-
pherins. After mitotic NE breakdown, Ran-GTP is concentrated
near mitotic chromatin, while the majority of Ran distal to chro-
mosomes is GDP bound. The presence of such a chromatin-
centered Ran-GTP gradient has been visualized in bothM-phase
Xenopus laevis egg extracts (XEEs) (Kalab et al., 2002) and
mitotic somatic cells (Kala´b et al., 2006). The mitotic Ran-GTPDevelopmegradient guides mitotic spindle assembly by releasing spindle
assembly factors from karyopherins in a spatially regulated
manner (Clarke and Zhang, 2008).
The conversion of Ran-GDP to Ran-GTP is catalyzed by a
Ran-specific guanine exchange factor (RanGEF), called regu-
lator of chromosome condensation 1 (RCC1), whose binding
to chromatin determines the asymmetrical distribution of Ran-
GTP throughout the cell cycle (Nemergut et al., 2001). The asso-
ciation of RCC1 to chromatin changes dramatically as XEE pro-
gresses through mitosis, with large increases in the amount of
chromatin-bound RCC1 shortly after the metaphase-anaphase
transition (Arnaoutov and Dasso, 2003). Mammalian RCC1
also shows changes in chromatin binding during the meta-
phase-anaphase window (Hutchins et al., 2004). The mecha-
nisms underlying altered association of RCC1 to chromatin
during anaphase are poorly understood. Nevertheless, the fact
that elevated levels of RCC1 can disrupt kinetochore structures
and spindle assembly checkpoint signaling (Arnaoutov and
Dasso, 2003) suggests that the dynamics of RCC1 have impor-
tant functional consequences.
RanBP1 is a Ran-GTP-binding protein (Beddow et al., 1995;
Bischoff et al., 1995) whose in vivo function has been obscure.
While RanBP1 is conserved between yeast and vertebrates, it
is not found in some invertebrate species, such as flies and
worms (Dasso, 2002). RanBP1 stimulates the enzymatic activity
of Ran’s GTPase-activating protein RanGAP1, roughly 10-fold
within in vitro assays using purified proteins (Bischoff et al.,
1995). In addition, karyopherins bind to Ran-GTP in a way that
prevents its interaction with RanGAP1, but RanBP1 can release
karyopherin binding and thereby allow RanGAP1-activated GTP
hydrolysis on Ran (Bischoff and Go¨rlich, 1997; Lounsbury and
Macara, 1997). RanBP1 also forms a stable heterotrimeric com-
plex with Ran and RCC1 in vitro, strongly inhibiting RCC1’s Ran-
GEF activity (Bischoff et al., 1995). The dynamics and potential
functions of this RCC1/Ran/RanBP1 heterotrimeric complex
(hereafter called the RRR complex) remain unresolved. Notably,
RanBP1 is excluded from nuclei (Richards et al., 1996), prevent-
ing RRR complex formation within nucleoplasm and reducing
RanBP1’s capacity to inhibit RCC1 during interphase. No such
barrier prevents RRR complex formation in mitosis.
We have investigated themitotic function and regulation of the
RRR complex using XEE, a well-established ex vivo model sys-
tem for cell-cycle studies (Arnaoutov and Dasso, 2003; Murray,
1991). We found that chromatin-based spindle assembly was
defective when RCC1 was present without RanBP1, in a manner
that could be corrected by restoration of RanBP1 to physiolog-
ical levels. The interaction between RanBP1 and RCC1 withinntal Cell 31, 393–404, November 24, 2014 ª2014 Elsevier Inc. 393
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B D Figure 1. RanBP1 Is Required in Normal
Spindle Assembly by Sequestering RCC1
(A) Different concentrations (0, 1,000, 3,000, and
10,000 units/ml) of demembraned sperm chromatin
were added and repurified from each sample. Total
CSF-XEE input (left half) and isolated chromatin
(right half) were subjected to immunoblotting
with antibodies against RCC1, RanBP1, and his-
tone H3.
(B) Mock-treated CSF-XEEs (left) or CSF-XEEs
depleted with anti-RanBP1 antibodies (right) were
examined by immunoblotting with antibodies
against RCC1, RanBP1, and histone H3.
(C) Recombinant xRCC1, with or without
xRanBP1, was added in to mock-treated CSF-XEE
or CSF-XEE depleted using anti-RanBP1 anti-
bodies. Rhodamine-labeled a-tubulin (20 mg/ml)
and demembraned chromatin (1,000 units/ml) were
added. After 30min at RT, aliquots of each reaction
were fixed, stained with Hoechst 33342, and pro-
cessed for fluorescent microscopy. Images were
taken for chromatin (left, blue) and tubulin (middle,
red). Scale bar, 10 mm. Spindles with chromatin in
vicinity were counted as one structure. Percentage
of bipolar spindles with chromatin correctly local-
izing at the midplate was plotted as mean ± SEM
(n = 3 XEEs, 50 structures counted in each XEE).
(D) Samples as in (C) were subjected to immuno-
blotting with antibodies against RCC1, RanBP1,
and histone H3.
See also Figure S1.
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RanBP1 Regulates RCC1 in MitosisXEE determined the partitioning of RCC1 between its chromatin-
bound and unbound forms, as well as the level of RanGEF
activity. Notably, RanBP1 was phosphorylated in a cell-cycle-
dependent manner, peaking in early anaphase. We mapped
the mitotically phosphorylated residue of RanBP1 and tested
whether this modification might control the mitotic dynamics
of RCC1. Consistent with this idea, a phosphomimetic muta-
tion of this site disrupted RRR complex assembly and promoted
increased loading of RCC1 onto mitotic chromosomes, while
a nonphosphorylatable RanBP1 mutant suppressed the normal
fluctuations of RCC1-chromatin binding at anaphase onset.
Together, our findings reveal an important mitotic role for
RanBP1, controlling the spatial distribution and magnitude of
the Ran-GTP gradient and thereby ensuring accurate execution
of Ran-dependent mitotic events.
RESULTS
Balance between RCC1 and RanBP1 Maintains Normal
Spindle Assembly
It is imaginable that somatic cells could maintain a mitotic chro-
mosome-centered Ran-GTP gradient by simply localizing RCC1
through its binding to chromatin. On the other hand, fertilized
Xenopus laevis eggs and other embryonic systems have a large
stored excess of many nuclear proteins, allowing them to go
through early cell cycles with only aminimal biosynthetic require-
ment (Dasso et al., 1992; Murray and Kirschner, 1989; Newport
and Kirschner, 1982). These embryonic systems thus possess394 Developmental Cell 31, 393–404, November 24, 2014 ª2014 ElsRCC1 in concentrations that grossly exceed the available chro-
mosomal binding sites, resulting in large untethered pools of
RCC1 (Dasso et al., 1992). To examine the distribution of
RCC1 in metaphase-arrested XEE (cytostatic factor [CSF]-
XEE), we added an increasing amount of demembraned sperm
chromatin that was allowed to assemble mitotic chromosomes
that were later repurified. As expected, western blotting showed
that the amount of RCC1 in the chromatin-bound fraction was
proportional to the original concentration of added chromatin
(Figure 1A). At low chromatin concentrations, the bulk of RCC1
was not chromatin bound. Indeed, soluble pools of RCC1 can
only be significantly depleted at very high concentrations of
added sperm chromatin, comparable to chromosome-to-cyto-
plasm ratios attained during or after the midblastula transition
(Newport and Kirschner, 1982). Chromatin binding causes a
modest, 2-fold stimulation of RCC1’s enzymatic activity (Nemer-
gut et al., 2001); nevertheless, a large, unbound pool of active
RCC1 should obscure a chromatin-centered Ran gradient. We
therefore wondered whether the unbound pool of RCC1 might
be inhibited, and we postulated that the formation of the RRR
complex (Bischoff et al., 1995) might be important in this context.
The bulk of RCC1 within interphase XEE is tightly associated
with RanBP1 (Pu and Dasso, 1997). We examined whether
RCC1 is similarly associated with RanBP1 in CSF-XEE, and
whether this might control its function in spindle assembly. We
immunodepleted RanBP1 from CSF-XEE and tested RCC1
levels before and after depletion by western blotting. We
observed that the majority of RCC1 (>90%) was codepletedevier Inc.
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RanBP1 Regulates RCC1 in Mitosiswith RanBP1 (Figure 1B). Since RanBP1 stably binds RCC1 only
in the presence of Ran (Bischoff et al., 1995), this finding sug-
gests that in the absence of chromatin most RCC1 remains
sequestered into the RRR complex in both interphase (Pu and
Dasso, 1997) and M phase (Figure 1B). We estimate that the
endogenous RanBP1 concentration in XEE is over 40-fold (molar
ratio) greater than that of RCC1 (Figure S1A available online), so
that RanBP1 levels aremore than sufficient to sequester RCC1 in
RRR complexes. As in interphase (Pu and Dasso, 1997), less
than 5% of the endogenous pool of Ran was depleted by anti-
RanBP1 antibodies.
Codepletion of RCC1 and RanBP1 allowed us to test whether
the RRR complex is important for mitotic spindle assembly by
adding back purified recombinant Xenopus RCC1 (xRCC1) and
RanBP1 (xRanBP1) individually and together (Figures 1C and
1D). In control CSF-XEE, normal bipolar spindles assembled
around sperm chromatin, with chromosomes aligned at a central
metaphase plate (Figure 1C, row 1). CSF-XEE lacking both
RanBP1 and RCC1 were incapable of assembling mitotic spin-
dles around chromatin, as would be expected in the absence
of RCC1 (Figure 1C, row 2; Kalab and Heald, 2008). Restoration
of endogenous xRCC1 levels rescued the assembly of spindle
microtubules (MTs), but these MTs consistently formed beside
the chromatin, apparently without normal engagement of the
MT network to the chromosomes (Figure 1C, row 3). Restoration
of both xRCC1 and xRanBP1 to physiological concentrations
rescued bipolar spindle assembly, with correct MT orientation
and chromosomes alignment on themetaphase plate (Figure 1C,
row 5). These findings confirm that RCC1 is essential for spindle
assembly in CSF-XEE and further indicate an essential role of
RanBP1 in spindle organization.
Undepleted CSF-XEEs were relatively tolerant of excess
RCC1: they assembled normal spindles when xRCC1 was
added to concentrations 10-fold higher than endogenous levels
(Figures S1B, rows 1–3, and S1C). When xRCC1 was added at
30-fold endogenous concentrations (Figures S1B, rows 4 and
5, and S1C), we observed defects in spindle organization similar
to those occurring when xRCC1 was added at endogenous con-
centrations to depleted CSF-XEE lacking RanBP1 (Figure 1C,
row 3). By contrast, depleted CSF-XEE to which we added re-
combinant xRCC1 at concentrations 10-fold higher than endog-
enous levels not only showed disengagement of spindle MTs
from chromosomes but also MT asters and spindles without
chromatin (Figure 1C, row 4), in a manner reminiscent of Ran-
GTP-stimulated MT structures (Carazo-Salas et al., 1999; Kalab
et al., 1999; Ohba et al., 1999; Zhang et al., 1999). These data
suggest that CSF-XEEs normally have a considerable capacity
to buffer RCC1 activity in the presence of physiological levels
of RanBP1, but that RCC1 can produce sufficient Ran-GTP to
cause aberrant MT structures when RanBP1 is absent. Consis-
tent with this idea, the formation of unanchored MT structures
was abolished when xRanBP1 was reconstituted to physiolog-
ical concentrations (Figure 1C, row 6).
A straightforward interpretation of these results is that a high
concentration of RanBP1 buffers the activity of RCC1 in CSF-
XEE through RRR complex assembly, so that levels of Ran-
GTP sufficient to disregulate MT assembly can only be achieved
at artificially high RCC1 concentrations that exceed this buffering
capacity. In the absence of RanBP1, the amount of RCC1Developmerequired to cause aberrant MT assembly becomes dramatically
lowered.
RCC1 Is Partitioned between Chromatin and the RRR
Complex
Endogenous RanBP1 did not associate with the chromatin frac-
tion (Figure 1A), and no RanBP1 was detected on chromatin
even when recombinant xRanBP1 was added to levels 10-fold
higher than the endogenous RanBP1 (Figure S2A). These data
suggested that the chromatin-bound and RRR-associated pools
of RCC1 were mutually exclusive. To test whether RRR complex
assembly and chromatin binding compete for RCC1, we added
increasing amounts of xRanBP1 to otherwise untreated CSF-
XEE containing a constant concentration of sperm chromatin.
While the total level of RCC1 remained unchanged (Figure 2A,
input), progressively less RCC1 bound to chromatin as xRanBP1
concentrations increased (Figure 2A, chromatin bound). To
further test the capacity of RanBP1 to modulate RCC1 binding
to chromatin, we compared the chromatin binding efficiency
of RCC1 in the presence and absence of RanBP1, using
RCC1- and RanBP1-depleted CSF-XEE. Increasing amounts
of recombinant xRCC1 were added in the presence or absence
of a constant level of recombinant xRanBP1 (Figure 2B, input).
We consistently found more RCC1 on chromatin in CSF-XEE
without RanBP1 than in samples with RanBP1 (Figure 2B, chro-
matin bound), indicating that RRR complex assembly directly
antagonized RCC1 chromatin binding.
To confirm that RanBP1 directly competes RCC1 from chro-
matin through RRR complex assembly, we compared the
chromatin distribution of recombinant wild-type (WT) xRCC1
(xRCC1WT) upon the addition of exogenous xRanBP1 to amutant
xRCC1 that does not bind Ran and that cannot form RRR com-
plexes (xRCC1Ran; Figure S2B). xRCC1WT or xRCC1Ran was
added to CSF-XEE at levels 10-fold higher than endogenous
RCC1 and allowed to preload onto chromatin. Increasing
amounts of recombinant xRanBP1 were then added (Figure 2C,
input). The amount of chromatin-bound xRCC1WT decreased
with xRanBP1 addition, while the level of xRCC1Ran on chromatin
remained constant (Figure 2C, chromatin bound), indicating
that xRanBP1 caused the dissociation of RCC1 from chromatin
specifically by RRR complex formation. Together, these findings
indicate that formation of RRR complexes is antagonistic RCC1
chromatin binding, so that the changes in the concentration of
RanBP1 modulate the partitioning of RCC1 between its chro-
matin-bound and soluble pools in CSF-XEE.
RRR Complex Assembly Suppresses RanGEF Activity
We wondered how RRR complex assembly might regulate enzy-
matic activity of RCC1 in egg extracts, given that RRR complex
assembly inhibits RCC1’s RanGEF activity in vitro (Bischoff
et al., 1995). We speculated that chromatin-bound RCC1 should
be active as a RanGEF, while soluble RCC1 should be inhibited
within RRR complexes, and that this pattern might promote the
formation of steep chromatin-centered Ran-GTP gradients in
CSF-XEE (Kalab et al., 2002). To test this idea, we first added
Ran-a-[32P]GDP into CSF-XEE without chromatin and measured
the kinetics of a-[32P]GDP release (Richards et al., 1995). In un-
treatedCSF-XEE, less than5%ofa-[32P]GDPwas releasedwithin
the first 30 s (Figures 3A–3C, green). Nucleotide release could bental Cell 31, 393–404, November 24, 2014 ª2014 Elsevier Inc. 395
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Figure 2. RanBP1 Competes with Chro-
matin in Binding RCC1
(A) Increasing concentrations of recombinant
xRanBP1 (03, 13, 33, 103, and 303 endogenous
RanBP1 level) were added to CSF-XEE. Reaction
aliquots (input) and isolated chromatin (chromatin)
were subjected to immunoblotting with indicated
antibodies. Relative chromatin bound RCC1 was
plotted against RanBP1 concentration (folds of
endogenous level).
(B) Recombinant xRCC1 was added at increasing
concentrations (03, 13, 33, 103, and 303 relative
to endogenous RCC1) to CSF-XEE previously
depleted using anti-RanBP1 antibodies. Each re-
action was divided, and either buffer (left) or re-
combinant RanBP1 (right) was added. Reaction
aliquots (input) and isolated chromatin (chromatin)
were subjected to immunoblotting with indicated
antibodies. Chromatin-bound RCC1 was plotted
against RCC1 concentration (folds of endogenous
level).
(C) Either recombinant WT RCC1 (RCC1WT) or an
RCC1 mutant that does not bind Ran (RCC1Ran)
was added into CSF-XEE at 103 endogenous
RCC1 levels. Recombinant xRanBP1 was added
to either sample at increasing concentrations (03,
13, 33, 103, and 303 relative to endogenous
RanBP1). Reaction aliquots (input) and isolated
chromatin (chromatin) were subjected to immu-
noblotting with indicated antibodies. Relative
chromatin-bound RCC1 was plotted against
RanBP1 concentration (folds of endogenous level).
All reactions contained 10,000 units/ml demem-
braned sperm chromatin and were incubated for
30 min at RT before being repurified.
See also Figure S2.
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RanBP1 Regulates RCC1 in Mitosisfurther inhibited through codepletion of RCC1 and RanBP1 (Fig-
ures 3A–3C, blue) or the addition of RanT24N, amutant that inhibits
RCC1 (Figures 3B and 3C, black), indicating that the low level of
nucleotide release that we observed required RCC1 activity.
When we added physiological concentrations of xRCC1 to
depleted CSF-XEE still lacking RanBP1, nearly 50% of a-[32P]
GDP was released from Ran within the first 30 s (Figures 3A–3C,
red). This change corresponded to more than a 15-fold increase
in estimated rate constant over the control CSF-XEE. The restora-
tion of physiological levels of recombinant xRanBP1 reduced
nucleotide release to a level comparable to control CSF-XEE
(Figures 3A–3C, light blue). These observations confirm that the
guanine nucleotide release activity of RCC1 in CSF-XEE without
chromatin was strongly inhibited by RRR complex assembly.
We predicted that the addition of chromatin to CSF-XEE
should increase endogenous guanine nucleotide releasing activ-
ity by competing RCC1 from the RRR complex. To test this idea,
we measured the change in a-[32P]GDP release within CSF-XEE396 Developmental Cell 31, 393–404, November 24, 2014 ª2014 Elsevier Inc.containing chromatin. a-[32P]GDP was
released at a higher rate in CSF-XEE
containing chromatin than in similar reac-
tions without chromatin, with the rates of
release being directly proportional to
the amount of chromatin (Figures 3D and
3E). Notably, a-[32P]GDP release couldbe entirely ascribed to the action of RCC1, since even the
maximum concentration of chromatin was ineffective in promot-
ing a-[32P]GDP release in CSF-XEE depleted of only RCC1 (Fig-
ures 3A, 3D, and 3E, black). As expected, the restoration of to
physiological RCC1 levels by addition of recombinant xRCC1 re-
constituted chromatin-sensitive a-[32P]GDP release activities
(Figures 3A, 3D and 3E, purple).
Taken together, our results suggest that chromatin-bound
RCC1 is the primary source of RanGEF activity in CSF-XEE,
with the soluble pool of RCC1 largely inhibited through the for-
mation of RRR complexes (Figure 3F). This binary regulation of
RCC1 activity should help to maintain a highly chromatin-
centered Ran-GTP gradient. This model predicts that if RCC1
in the soluble fraction were not controlled by RRR complex as-
sembly, Ran-GTP would also be produced in regions distal to
chromatin, resulting in defective MT organization with respect
to chromosomes. Our observations in CSF-XEE containing
RCC1 but lacking RanBP1 are consistent with this prediction
AD E F
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Figure 3. RanBP1 Complex Inhibited RCC1 in Mitotic Cytosol
(A) RCC1 and RanBP1 were depleted from CSF-XEE using anti-RanBP1 antibodies (lanes 2–4). Buffer (lane 2) or physiological concentrations of recombinant
xRCC1 (lane 3) or recombinant xRCC1 and xRanBP1 (lane 4) were added back to the depleted CSF-XEE. Total CSF-XEE was subjected to immunoblotting by
indicated antibodies. Lane 1 shows undepleted control CSF-XEE.
(B) Tenmicromolar recombinant Ran chargedwith a-[32P]GDPwas added to CSF-XEE reactions as in (A), or to undepleted CSF-XEE containing 10 mMRan-T24N.
Aliquots were taken at 0.5, 1.5, and 5 min after a-[32P]Ran-GDP addition, and exchange was monitored using a filter binding assay.
(C) Rate constants were determined from (B) and plotted as mean ± SEM. Significance in difference was tested by two-tailed t test (n = 3, ***p < 0.0001).
(D) Demembraned sperm chromatin was added at the indicated concentrations to CSF-XEE, CSF-XEE depleted with anti-RCC1 antibodies, or RCC1-depleted
CSF-XEE with recombinant xRCC1 (13 physiological concentration). Aliquots were sampled and analyzed as in (B).
(E) Rate constants were determined from (D) and plotted as mean ± SEM. Significance in difference was tested by two-tailed t test (n = 3, **p < 0.002, ***p <
0.0005).
(F) RCC1 distribution equilibrium. Chromatin-bound RCC1 is an active RanGEF, while RCC1 within the RRR complex in mitotic cytosol is inactive. These two
pools are in a dynamic equilibrium, determined by RanBP1 concentrations.
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RanBP1 Regulates RCC1 in Mitosis(Figures 1A, rows 3 and 4, and 1B). It is surprising in this light that
beads coated with recombinant RCC1 protein are capable of
organizing spindles in CSF-XEE (Halpin et al., 2011); we would
have naively predicted that RRR complex assembly should
silence their capacity for Ran-GTP production. However, the
tagged RCC1 protein linked to these beads does not effectively
form RRR complexes (R. Heald, personal communication),
potentially explaining its capacity to remain enzymatically active
despite the presence of excess RanBP1.
RanBP1 Is Phosphorylated in a Cell-Cycle-Dependent
Manner
The chromatin binding dynamics of RCC1 vary during mitosis in
both XEE (Arnaoutov and Dasso, 2003) andmammalian cells (Hi-Developmetakomate et al., 2010; Hutchins et al., 2004). Particularly, RCC1
accumulates on chromatin at anaphase onset in cycling XEE (Ar-
naoutov and Dasso, 2003), and we wondered whether RRR
complex-dependent partitioning of RCC1 between the chro-
matin-bound and unbound pools might play a role in this phe-
nomenon. Earlier studies have demonstrated mitotic regulation
of mammalian RanBP1 through degradation and phosphoryla-
tion (Ciciarello et al., 2010; Hwang et al., 2011). We did not find
any evidence that RanBP1 was subject to degradation during
multiple cell cycles within cycling XEE (Figure 4A, input). How-
ever, when we examined RanBP1 by immunoprecipitation at
different time points after adding g-[32P]ATP to cycling XEE to la-
bel the endogenously phosphorylated proteins, we observed
that it was modified in a dynamic manner, with the highest levelntal Cell 31, 393–404, November 24, 2014 ª2014 Elsevier Inc. 397
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Figure 4. RanBP1 Is Phosphorylated on
Cell-Cycle Basis
(A) We added 100 mCi/ml g-[32P]ATP to cycling
XEE. RanBP1 was immunoprecipitated from
the reaction at different times and subjected to
SDS-PAGE. XEE aliquots (input) and RanBP1
immunoprecipitates (anti-RanBP1 IP, row 1)
were subjected to immunoblotting with indicated
antibodies, and 32P within the RanBP1 immuno-
precipitate was detected by autoradiography (anti-
RanBP1 IP, row 2).
(B) The immunoblot intensity of Cyclin B for each
sample from (A) was measured and normalized
relative to the maximum Cyclin B intensity (blue
line). 32P associated with immunoprecipitated
RanBP1 for each sample was similarly measured,
and normalized values for each time point are
shown (red line).
(C) RanBP1 was immunoprecipitated from cycling
XEE at anaphase onset or interphase (interphase).
RanBP1 precipitated from anaphase was treated
with either buffer only (anaphase) or alkaline
phosphatase (anaphase + phosphatase treat-
ment). The RanBP1 within each sample was
separated by linear pH 4–7 IEF followed by SDS-
PAGE and subjected to immunoblotting with anti-
bodies against RanBP1. The numbers above show
the estimated pI of individual dot.
(D) Relative RanBP1 intensity for each major spot
in (C) was calculated by dividing intensity of each dot to total RanBP1 intensity. The relative RanBP1 intensity of anti-RanBP1 IP from anaphase (blue line), anti-
RanBP1 IP from anaphase followed by calf intestinal alkaline phosphatase treatment (green line), and anti-RanBP1 IP from interphase (red line) were plotted
against pI of each dot from (C).
See also Figure S3.
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RanBP1 Regulates RCC1 in Mitosisof RanBP1 phosphorylation (50–60min) slightly after the onset of
Cyclin B degradation (40–50 min) at anaphase onset (Figures 4A
and 4B).
We further examined the phosphorylation dynamics of endog-
enous RanBP1 by 2D gel electrophoresis. RanBP1was immuno-
precipitated from either anaphase or interphase cycling XEE.
The sample from anaphase XEE was treated with alkaline phos-
phatase or buffer only, and all samples were separated by iso-
electric focusing (IEF) and SDS-PAGE (Figure 4C). The samples
gave foci with isoelectric points (pIs) near pHs 5.14, 5.21, and
5.28. During anaphase, around 25% of RanBP1 was found in
the most acidic fraction, pH 5.14 (Figures 4C, anaphase, and
4D, blue line). After phosphatase treatment, this species was
depleted (Figures 4C, anaphase/phosphatase treated, and 4D,
green line), suggesting that it corresponds to phosphorylated
RanBP1. During interphase, only around 10% of RanBP1
focused to pI = 5.14 (Figures 4C, interphase, and 4D, red line),
indicating that significantly less RanBP1 is phosphorylated in
interphase XEE than during anaphase. Taken together, our find-
ings suggest that much of the endogenous pool of RanBP1 be-
comes phosphorylated in a cell-cycle-dependent manner in
cycling XEE, peaking just after the onset of anaphase.
To determine the role of RanBP1 phosphorylation, we identi-
fied the site of itsmodification. RanBP1was immunoprecipitated
from anaphase-cycling XEE and analyzed bymass spectrometry
(Figure S3A). The major phosphorylated residue in this sample
was Ser60 of RanBP1, which had previously been implicated
as a potential site of mitotic phosphorylation in HeLa cells
(Hwang et al., 2011). To further validate the Ser60 phosphoryla-398 Developmental Cell 31, 393–404, November 24, 2014 ª2014 Elstion on xRanBP1, a phospho-specific antibody was raised
against xRanBP1 pSer60. By examining RanBP1 isolated from
cycling XEE at different time points, we found that Ser60 phos-
phorylation peaked at anaphase, at or slightly after the onset
Cyclin B degradation (Figure S3B).
RanBP1 Ser60 Phosphorylation Disrupts the RRR
Complex
Ser60 lies within the Ran-GTP binding domain of RanBP1, and
it is conserved across a wide variety of vertebrate species
(Figure 5A). This residue is not conserved in budding or fission
yeast, nor is it conserved within human RanBP2 and RanBP3
(Figure S4), related proteins that share structurally similar Ran-
GTP binding domains (Vetter et al., 1999). To test whether
this modification can alter the formation of RRR complexes,
we produced recombinant nonphosphorylatable (xRanBP1S60A)
or phosphomimetic (xRanBP1S60D) mutant forms of RanBP1.We
analyzed their in vitro Ran-GTP binding affinity and observed that
Ran-GTP binding was similar in xRanBP1S60A, xRanBP1S60D,
and WT xRanBP1WT (Figure 5B), suggesting that Ser60 phos-
phorylation does not affect the capacity of RanBP1 to bind
Ran-GTP. The finding that Ran-GTP binding was similar for
each of these proteins also suggested that the point mutations
did not grossly disrupt xRanBP1’s structure.
We analyzed the capacity of the mutated xRanBP1 proteins
to form RRR complexes in vitro, through addition of WT or
mutated xRanBP1 to preformed RCC1/Ran complexes (Bischoff
et al., 1995). Ran-GDP was used instead of Ran-GTP to mini-
mize the interference from RanBP1/Ran-GTP interaction, sinceevier Inc.
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Figure 5. RanBP1 Ser60 Phosphorylation Releases RCC1 to Bind
Chromatin
(A) Protein sequence alignment of RanBP1 from Homo sapiens, Mus muscu-
lus, Xenopus laevis, and Danio rerio. The numbers indicate the respective
positions of the first and last amino acid residue withinHomo sapiens RanBP1.
Ser60 is in red.
(B) Recombinant His-S-Ran-GTP was incubated with recombinant
xRanBP1WT, xRanBP1S60A, or xRanBP1S60D. Complexes formed by His-S-
Ran-GTP were precipitated using Ni-NTA resin. The original reactions (input)
and precipitated proteins (Ni-NTA pull-down) were separated by SDS-PAGE
and visualized by CBB staining. As a control, a reaction was incubated in par-
allel, containing recombinant xRanBP1WT but lacking His-S-Ran-GTP (lane 1).
(C) Recombinant xRCC1-HA and His-S-Ran-GDP were allowed to bind, fol-
lowed by the addition of recombinant xRanBP1WT, xRanBP1S60A, or
xRanBP1S60D and further incubation. xRCC1-HA and associated proteins
were precipitated using anti-HA beads. The original reactions (input) and
precipitated proteins (anti-HA IP) were separated by SDS-PAGE and visual-
ized by CBB staining. As a control, a reaction was incubated in parallel, con-
taining xRCC1-HA and xRanBP1WT but lacking His-S-Ran-GDP (lane 1).
See also Figure S4.
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of RCC1 (Bischoff et al., 1995). Interestingly, while the RRR com-
plex was formed equally well with xRanBP1WT and xRanB-
P1S60A, xRanBP1S60D showed greatly reduced RRR complex
levels (Figure 5C). This finding suggests that introducing nega-
tive charge at Ser60 on RanBP1 profoundly inhibits RRR com-Developmeplex assembly and that phosphorylation of RanBP1 is likely to
cause dissociation of the RRR complex during anaphase in
cycling XEE.
RanBP1 Ser60 Phosphorylation Alters RCC1 Activity
in XEE
To test the effect of RanBP1 phosphorylation on the amount
of chromatin-bound RCC1, we added chromatin and physio-
logical concentrations of xRCC1 to CSF-XEE that had been
immunodepleted of endogenous RanBP1 and RCC1, along
with physiological concentrations of xRanBP1WT, xRanBP1S60A,
or xRanBP1S60D. As before (Figure 2B), higher levels of RCC1
were detected on chromatin in the absence of RanBP1 than in
untreated CSF-XEE (Figure 6A, lanes 1 and 2), and this effect
was reversed upon restoration of normal levels of xRanBP1WT.
Recombinant xRanBP1WT at concentrations roughly 3-fold
higher than endogenous levels further reduced the amount of
RCC1 bound to chromatin (Figure 6A, lanes 3 and 4). The reac-
tions with xRanBP1S60A showed levels of chromatin-bound
RCC1 that were very similar to those observed with xRanBP1WT
(Figure 6A, lanes 5 and 6). However, phosphomimetic
xRanBP1S60D was far less effective in releasing RCC1 from
chromatin (Figure 6A, lanes 7 and 8), consistent with the
idea that it could not effectively release chromatin-bound
RCC1 into the soluble pool through RRR complex formation.
We further analyzed the capacity xRanBP1WT, xRanBP1S60A,
or xRanBP1S60D to modulate RanGEF activity. Chromatin and
physiological levels of recombinant xRCC1 were added to
depleted CSF-XEE, together with xRanBP1WT, xRanBP1S60A,
or xRanBP1S60D (Figures 6B–6D). RanGEF activity in each sam-
ple was estimated using a guanine nucleotide release assay (Fig-
ures 6C and 6D). As before (Figure 3), CSF-XEE reactions
showed a chromatin- and RCC1-dependent guanine nucleotide
release activity that was partially inhibited by the addition of
xRanBP1WT (Figures 6C and 6D, compare red and purple) and
xRanBP1S60A was equally effective in inhibition of guanine nucle-
otide release (green). However, xRanBP1S60D was significantly
less effective than xRanBP1WT (light blue), correlating well with
its limited capacity to release RCC1 from chromatin (Figure 6A).
To test whether RanBP1 phosphorylation was important for
RCC1 dynamics in the context of anaphase progression, we
examined the effect of RanBP1S60A on RCC1 chromatin binding
in cycling XEE (Arnaoutov and Dasso, 2003). Although treat-
ments required to immunodeplete RanBP1 disrupted mitosis in
cycling XEEs, these extracts remained functionally intact when
recombinant xRanBP1WT or xRanBP1S60A was added to other-
wise untreated cycling XEEs at levels approximately 2-fold
above endogenous levels. As these XEEs progressed through
the cell cycle, we prepared chromatin from samples taken during
the first interphase, anaphase of the first M phase, and second
interphase. Samples with xRanBP1WT showed lower overall
levels of chromatin-bound RCC1 than buffer-treated controls
(Figure 6E), as might be expected (Figure 2A). Importantly, the
reaction containing xRanBP1WT still showed a transient, 2-fold
increase in chromatin-bound RCC1 during anaphase, which
was similar in magnitude to the transient increase observed in
untreated XEE. By contrast, the chromatin binding dynamics of
RCC1 was significantly dampened in cycling XEE with xRanB-
P1S60A, showing less than a 30% increase in chromatin-boundntal Cell 31, 393–404, November 24, 2014 ª2014 Elsevier Inc. 399
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Figure 6. Endogenous RanGEF Activity in CSF-XEE Is Increased by RanBP1 Phosphorylation on Ser60
(A) xRCC1 was restored to physiological levels in CSF-XEE depleted using anti-RanBP1 antibodies by adding recombinant xRCC1. Recombinant xRanBP1WT,
xRanBP1S60A, or xRanBP1S60Dwas added as indicated (13 or 33 endogenous RanBP1 levels). Then, 10,000 units/ml demembraned sperm chromatin was added
to each sample and incubated for 30 min at RT before chromatin isolation. Each total reaction (XEE input) and the isolated chromatin (chromatin) were subjected
to immunoblotting with antibodies against RCC1, RanBP1, and histone H3, as indicated.
(B) CSF-XEE was depleted using anti-RanBP1 antibodies, followed by addition of buffer or physiological levels of xRCC1. Where indicated, recombinant
xRanBP1WT, xRanBP1S60A, or xRanBP1S60D was added at concentrations equivalent to endogenous RanBP1. Each sample was subjected to immunoblotting
with antibodies against RCC1, RanBP1, and histone H3.
(C) Ten micromolar recombinant Ran charged with a-[32P]GDP was added CSF-XEE reactions as in (B) containing demembraned sperm chromatin
(10,000 units/ml). Aliquots were taken at 0.5, 1.5, and 5 min after a-[32P]Ran-GDP addition, and exchange was monitored using a filter binding assay, and plotted
as described in Figure 3.
(D) Rate constants were determined from nucleotide release data (C) and plotted as mean ± SEM. Significance in difference was tested by two-tailed t test (n = 3,
***p < 0.0001).
(E) Cycling XEE containing demembraned sperm chromatin (3,000 units/ml) was warmed to RT and allowed to initiate NE assembly. After NE closure, buffer (left),
recombinant xRanBP1WT (middle), or xRanBP1S60A (right) was added at roughly twice the endogenous RanBP1 level. Chromatin was prepared from each sample
at the first interphase (Int1), anaphase onset of the first mitosis (M1), and the second interphase (Int2). Total cycling XEE input at these three points was subjected
to immunoblotting with antibodies against RCC1 and RanBP1 (rows 1 and 2). Isolated chromatin from each sample at these three points was subjected to
immunoblotting by antibodies against RCC1 and histone H3 (rows 3 and 4). Chromatin-bound RCC1 levels were normalized to the RCC1 signal intensity at Int1 for
individual sample. The normalized RCC1 level on chromatin was plotted as mean ± SEM (n = 3).
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RanBP1 Regulates RCC1 in MitosisRCC1 in anaphase over interphase. This small increase might be
ascribed to the endogenous RanBP1 that remained in the extract
and could become phosphorylated at anaphase onset. The ca-
pacity of xRanBP1S60A to suppress RCC1’s anaphase chromatin
binding dynamics strongly implies that RanBP1 Ser60 phos-
phorylation is critical for this regulation.
Taken together, our results show that anaphase phosphoryla-
tion on RanBP1 Ser60 increases the partitioning of RCC1 to
chromatin and thereby drives increased Ran-GTP production
in late mitosis.
DISCUSSION
It has been known for nearly two decades that RCC1, Ran, and
RanBP1 form a stable heterotrimeric complex (RRR complex),
which inhibits RCC1’s RanGEF activity in vitro (Bischoff et al.,
1995). The function of the RRR complex has remained myste-
rious, however, because RanBP1 is physically separated from
RCC1 during interphase (Richards et al., 1996) and the formation
of this complex has been presumed to have little role in regu-
lating nuclear transport, if any. We have demonstrated that the
RRR complex forms readily in M-phase CSF-XEEs (Figure 1).
RCC1 binding to chromatin and RRR complex assembly were
mutually exclusive, so that promoting RRR complex formation
through the addition of recombinant xRanBP1 sequestered
RCC1 away from chromatin (Figure 2A). Moreover, RRR com-
plex assembly inhibited RCC1’s RanGEF activity in CSF-XEE
(Figure 3), in agreement with earlier in vitro observations (Bis-
choff et al., 1995). Together, these findings suggest that the
RRR complex plays a pivotal mitotic role in determining the
partitioning of RCC1 between its active chromatin-bound and
inactive soluble states, thereby setting both the location and
magnitude of Ran-GTP production during mitosis.
Our observations suggest that RCC1 inhibition through RRR
complex assembly helps to organize Ran-GTP production and
limit it to the close vicinity of mitotic chromatin. Inappropriate
Ran-GTP production in the absence of RanBP1 can lead to the
assembly of defective spindles and ectopic MT assembly in
XEE (Figure 1). This mitotic function of RanBP1 may be particu-
larly critical in Xenopus embryos and extracts, given the high
concentration of RCC1 relative to chromatin binding sites within
the early embryo (Figure 1A; Dasso et al. 1992). Nevertheless,
there is evidence that RanBP1 may play a similar role in somatic
systems. For example, tissue culture cells depleted of RanBP1
show disorganized MT asters (Li et al., 2007), hyperstable spin-
dle MTs, and defective chromosome segregation (Tedeschi
et al., 2007). Notably, RanBP1 is downregulated in aging cells
(Ly et al., 2000; Pujol et al., 2002), which show relatively shallow
Ran-GTP gradients (Hasegawa et al., 2013). Finally, RanBP1
expression is misregulated in a variety of human cancers (Re-
nsen et al., 2008). Our results and other findings (Amato et al.,
2013) suggest the possibility that this misregulation may
contribute toward mitotic defects in these cells.
Furthermore, it has been well established that RCC1’s associ-
ation to mitotic chromatin is dynamic and that there are particu-
larly large changes as cycling XEE (Arnaoutov and Dasso, 2003)
or mammalian tissue culture cells (Hutchins et al., 2004) pass
through the metaphase-to-anaphase window. While a number
of posttranslational modifications of RCC1 have been describedDevelopmepreviously (Chen et al., 2007; Hutchins et al., 2004; Li and Zheng,
2004), none of these appear to be responsible for control of
RCC1 at anaphase onset. In particular, mitotic cdk1-dependent
phosphorylation of RCC1 is not well correlated temporally to
changes in RCC1-chromatin association, since it occurs much
earlier in mitosis (Hutchins et al., 2004; Li and Zheng, 2004). It
is also notable that the residues of human RCC1 that have
been found as the primary targets of cdk1-dependent phosphor-
ylation (serine resides 2 and 11; Hutchins et al., 2004; Li and
Zheng, 2004) are not conserved in Xenopus laevis, so that their
modifications could not modulate RCC1 association to chro-
matin in XEE (Arnaoutov and Dasso, 2003). We observed that
RanBP1 is phosphorylated during anaphase in cycling XEE (Fig-
ures 4 and S3) and that this modification disrupts RRR complex
assembly (Figure 5). Our data suggest that modification of
RanBP1 drives changes in RCC1 binding to chromatin and
thereby indirectly alters the rate of Ran-GTP production in
anaphase (Figure 7).
We speculate that this regulation may also contribute to Ran
pathway organization in early interphase. Enhanced activity of
RCC1 on anaphase chromatin should help provide high levels
of Ran-GTP to facilitate NE reassembly (Clarke and Zhang,
2008). Moreover, physical separation of RCC1 and RanBP1 after
RRR complex dissociation would allow RCC1 sequestration to
chromatin within reforming nuclei while excluding RanBP1 into
the early interphase cytosol. We expect that one detrimental
effect of interphase NE rupture would be the loss of RanBP1
exclusion from nucleoplasm, resulting in RRR complex formation
and decreased levels of active, chromatin-bound RCC1, which
in turn could decrease Ran-GTP production and contribute to
the general loss of compartmental identity that has been
observed under these circumstances (Hatch et al., 2013).
The conservation of the Ser60 residue (Figure 5A) is consistent
with the idea that phosphorylation of RanBP1may play an impor-
tant role in mitotic regulation of the Ran pathway in many verte-
brate species. On the other hand, the absence of this residue in
budding and fission yeast suggests that although RanBP1 may
have mitotic roles in fungi (Ouspenski, 1998), those functions
are controlled through different mechanisms. This divergence
may reflect the fact that yeast do not undergo NE breakdown
during mitosis and thus do not have complete mixing of their
nuclear and cytoplasmic contents. More interestingly, Caeno-
rhabditis elegans and Drosophila melanogaster apparently not
only lack this regulatory pathway but also appear to be devoid
of RanBP1 homologs altogether, although they still possess
potential homologs of RanBP2 and RanBP3 (Dasso, 2002). It is
notable that the worm and fly RCC1 homologs possess
extended N- or C-terminal domains, respectively, that are not
found in vertebrate and fungal RCC1 homologs. In the case of
Drosophila, this additional domain shares sequence homology
with embryonic linker histones (Frasch, 1991). We speculate
that worm and fly RCC1may interact with chromatin in a different
fashion than vertebrate RCC1 proteins, thus bypassing any
requirement for RanBP1. Testing this idea in the future will be
of considerable interest and will be important for understanding
how the use of the Ran pathway has evolved in different
organisms.
In summary, we have documented an important mitotic role of
the RanBP1 protein in controlling the localization and activity ofntal Cell 31, 393–404, November 24, 2014 ª2014 Elsevier Inc. 401
Figure 7. Model for Mitotic Regulation of
RCC1 by RanBP1
Premetaphase: RCC1 is partitioned between an
active, chromatin-bound pool (green) and an
inactive pool (gray), associated with RRR com-
plexes that also contain RanBP1 and nucleotide-
free Ran (gray). Anaphase onset: phosphorylation
of RanBP1 on Ser60 (asterisk) releases RCC1 from
the RRR complex. The free RCC1 is then recruited
to chromatin. Anaphase: the high level of chro-
matin-bound RCC1 promotes enhanced levels of
Ran-GDP (red) to Ran-GTP (green) exchange on
chromatin. Interphase: NE (yellow) formation
physically separates RCC1 from RanBP1, pre-
venting RRR complex assembly and inhibition of
RCC1.
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RanBP1 Regulates RCC1 in MitosisRan’s nucleotide exchange factor RCC1. We have shown that
phosphorylation of RanBP1 during anaphase drives changes in
RCC1 dynamics and allows increased Ran-GTP production.
These findings resolve important and long-standing questions
within the Ran field regarding the function of the heterotrimeric
RRR complex and its dynamics.EXPERIMENTAL PROCEDURES
Antibody and Immunodepletion
Rabbit polyclonal antibodies against xRCC1 were described previously (Ar-
naoutov and Dasso, 2003). Rabbit polyclonal antibodies against full-length
xRanBP1 and phospho-specific rabbit polycolonal antibodies against a syn-
thetic xRanBP1-based phosphorylated peptide (KMRAKLFRFApSEND) were
produced by Pacific Immunology. Rabbit polyclonal antibodies against his-
tone H3 (ab1791) and mouse monoclonal antibodies against Xenopus Cyclin
B2 (ab18250) were purchased from Abcam. Immunodepletions were per-
formed by incubating XEE with anti-xRCC1 and anti-xRanBP1 crosslinked to
protein A beads.
XEE Preparation and Use
CSF-XEE and demembraned sperm nuclei were prepared as described in
Murray (1991). To examine spindle assembly, rhodamine-tubulin (20 mg/ml;
Cytoskeleton) and sperm nuclei (1,000 unit/ml XEE) were added to CSF-XEE
and incubated at room temperature (RT) for 60 min. Aliquots were fixed with
11% paraformaldehyde supplemented with 10 mg/ml DAPI and processed
for fluorescent microscopy. Images (Figures 1B and S1B) were taken using
an ORCA-II charge-coupled device camera on a Zeiss Axioskop microscope,
and the images were acquired and processed with Openlab software
(PerkinElmer).
To analyze chromatin-bound proteins, demembraned sperm nuclei were
added to a final concentration of 10,000 units/ml XEE and incubated at RT
for 30 min. Reactions were diluted in dilution buffer (5 mM HEPES [pH 7.7],
50 mM KCl, 1 mM MgCl2, 0.2% Triton X-100, and 5% (v/v) glycerol), and
spun through cushion buffer (5 mM HEPES [pH 7.7], 50 mM KCl, 1 mM
MgCl2, 0.2% Triton X-100, and 30% (v/v) glycerol) at 11,000 3 g for 5 min.
The chromatin was washed once with dilution buffer and recentrifuged under
the same conditions. The chromatin pellet was boiled in SDS sample buffer
and subjected to SDS-PAGE and western blot analysis. All procedures402 Developmental Cell 31, 393–404, November 24, 2014 ª2014 Elsevier Inc.involving frogs were approved by the NICHD Ani-
mal Care and Use Committee (ASP-12-025).
Immunoprecipitation of RanBP1
and Phosphatase Treatment
of Bead-Bound RanBP1
Cycling XEE was frozen in liquid nitrogen in
different time points. Fifty microliters of XEE fromanaphase XEE or interphase XEE was thawed and diluted at 1:10 (v/v) in dena-
tured buffer (20 mM HEPES [pH 7.7], 150 mM NaCl, 0.2% Triton X-100, and
1 M urea). Twenty-five micrograms of anti-xRanBP1 antibodies was cross-
linked on 100 ml of protein A magnetic beads (Invitrogen) and incubated with
each sample for 90 min at 4C. The beads were washed three times in 13
NEBuffer 3 (New England Biolabs) and resuspended in 50 ml of 13 NEBuffer
3. Either buffer or 10 units of alkaline phosphatase (NEB, M0290S) was added
to the anaphase XEE beads and incubated 30C for 30 min to allow dephos-
phorylation of the phosphatase-treated sample. After incubation, beads
were washed three times with 13 NEBuffer 3 and eluted with DeStreak Rehy-
dration Solution (GE Healthcare). The eluted samples were separated by 2D
gel electrophoresis.
Phosphorylated Amino Acid Residue Mapping
Endogenous RanBP1 from anaphase cycling XEE was immunoprecipitated
using anti-xRanBP1 antibodies crosslinked to protein A Sepharose beads
(GE Healthcare). After immunoprecipitation, proteins were eluted and sepa-
rated by SDS-PAGE. The region of the gel containing RanBP1 was isolated
and extracted. Sequence analysis was performed at the Harvard Mass
Spectrometry and Proteomics Resource Laboratory (Cambridge, MA) by mi-
crocapillary reverse-phase high-performance liquid chromatography nano-
electrospray tandemmass spectrometry on a Thermo Scientific LTQ-Orbitrap
mass spectrometer.
Endogenous Guanine Nucleotide Releasing Assay
Ten micromolar recombinant Human Ran loaded with a-[32P]GDP was added
to CSF-XEE. Aliquots were diluted in stop buffer (20 mM Tris-HCl [pH 7.5],
25mMMgCl2, 100mMNaCl, and 1mMdithiothreitol), and a-[
32P]GDP binding
to Ran was measured by filter retention. Triplicate samples were analyzed
for each condition. Nucleotide release from the loaded Ran was plotted
analyzed using Prism software. The guanine nucleotide releasing curve
showing mean ± SEM was regressed as one-phase decay model. The rate
constant for each reaction was also plotted as mean ± SEM, and the signifi-
cances in difference were analyzed by two-tailed t test.
In Vitro Protein Binding Assay
In vitro protein bindingwas performed in protein binding buffer (20mMHEPES,
150 mM NaCl, 50 mg/ml digitonin [Calbiochem], and 2 mM MgCl2). To
check Ran-GTP binding affinity (Figure 5A), recombinant Xenopus RanBP1WT,
RanBP1S60A, or RanBP1S60D was incubated with recombinant Human
His-S-Ran-GTP, and the pull-down assay was done by incubating
Developmental Cell
RanBP1 Regulates RCC1 in Mitosissamples with nickel-nitrilotriacetic acid (Ni-NTA) resin (QIAGEN). To check
RRR heterotrimeric complex formation (Figure 5B), recombinant WT/mutated
Xenopus RanBP1 was incubated with recombinant Human His-S-Ran-GDP,
and recombinant Xenopus RCC1-hemagglutinin (HA). The immunoprecipita-
tion was done by incubating samples with anti-HA affinity gel (Sigma-Aldrich).
To characterize Ran binding mutant of RCC1 (Figure S2), recombinant Xeno-
pus RCC1WT or RCC1Ran was incubated with recombinant human His-S-Ran-
GTP. The pull-down was done by incubating samples with S protein agarose
(Novagen).
All bound proteins were eluted and boiled in SDS-sample buffer, separated
by SDS-PAGE, and visualized by Coomassie brilliant blue (CBB) staining.
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